Prostate cancer antigen 3: diagnostic outcomes in men presenting with urinary prostate cancer antigen 3 scores ≥100.

[1]  L. Klotz.  Active Surveillance for Prostate Cancer: Overview and Update , 2013, Current Treatment Options in Oncology.

[2]  R. Coda,et al.  Histological chronic prostatitis and high‐grade prostate intra‐epithelial neoplasia do not influence urinary prostate cancer gene 3 score , 2012, BJU international.

[3]  Thomas Hambrock,et al.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.

[4]  G. Jenster,et al.  2239 PCA3 SCORE CHANGE OVER TIME IN A PROSTATE CANCER SCREENING POPULATION , 2012 .

[5]  M. Cooperberg,et al.  Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer , 2011, Prostate Cancer and Prostatic Diseases.

[6]  T. Klatte,et al.  Age-specific PCA3 score reference values for diagnosis of prostate cancer , 2012, World Journal of Urology.

[7]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[8]  H. G. van der Poel,et al.  Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. , 2011, European urology.

[9]  R. V. D. van den Bergh,et al.  Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100). , 2010, European urology.

[10]  R. V. D. van den Bergh,et al.  Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test. , 2010, European urology.

[11]  J. Schalken,et al.  The use of PCA3 in the diagnosis of prostate cancer , 2009, Nature Reviews Urology.

[12]  M. Roobol,et al.  Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands) , 2003, BJU international.

[13]  L. Kiemeney,et al.  DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer , 2003 .

[14]  W. Isaacs,et al.  DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.